ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-17 |

Results: 17

PROSTAGLANDIN E-2 INCREASES BONE STRENGTH IN INTACT RATS AND IN OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA

Authors: KE HZ SHEN VW QI H CRAWFORD DT WU DD LIANG XG CHIDSEYFRINK KL PIRIE CM SIMMONS HA THOMPSON DD

Citation: Hz. Ke et al., PROSTAGLANDIN E-2 INCREASES BONE STRENGTH IN INTACT RATS AND IN OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA, Bone (New York, N.Y.), 23(3), 1998, pp. 249-255

DISCOVERY AND PRECLINICAL PHARMACOLOGY OF A NOVEL, POTENT, NONSTEROIDAL ESTROGEN-RECEPTOR AGONIST ANTAGONIST, CP-336156, A DIARYLTETRAHYDRONAPHTHALENE/

Authors: ROSATI RL JARDINE PD CAMERON KO THOMPSON DD KE HZ TOLER SM BROWN TA PAN LC EBBINGHAUS CF REINHOLD AR ELLIOTT NC NEWHOUSE BN TJOA CM SWEETNAM PM COLE MJ ARRIOLA MW GAUTHIER JW CRAWFORD DT NICKERSON DF PIRIE CM QI H SIMMONS HA TKALCEVIC GT

Citation: Rl. Rosati et al., DISCOVERY AND PRECLINICAL PHARMACOLOGY OF A NOVEL, POTENT, NONSTEROIDAL ESTROGEN-RECEPTOR AGONIST ANTAGONIST, CP-336156, A DIARYLTETRAHYDRONAPHTHALENE/, Journal of medicinal chemistry, 41(16), 1998, pp. 2928-2931

EFFECTS OF CP-336,156, A NEW, NONSTEROIDAL ESTROGEN AGONIST ANTAGONIST, ON BONE, SERUM-CHOLESTEROL, UTERUS, AND BODY-COMPOSITION IN RAT MODELS/

Authors: KE HZ PARALKAR VM GRASSER WA CRAWFORD DT QI H SIMMONS HA PIRIE CM CHIDSEYFRINK KL OWEN TA SMOCK SL CHEN HK JEE WSS CAMERON KO ROSATI RL BROWN TA DASILVAJARDINE P THOMPSON DD

Citation: Hz. Ke et al., EFFECTS OF CP-336,156, A NEW, NONSTEROIDAL ESTROGEN AGONIST ANTAGONIST, ON BONE, SERUM-CHOLESTEROL, UTERUS, AND BODY-COMPOSITION IN RAT MODELS/, Endocrinology, 139(4), 1998, pp. 2068-2076

COMPARATIVE EFFECTS OF DROLOXIFENE, TAMOXIFEN, AND ESTROGEN ON BONE, SERUM-CHOLESTEROL, AND UTERINE HISTOLOGY IN THE OVARIECTOMIZED RAT MODEL

Authors: KE HZ CHEN HK SIMMONS HA QI H CRAWFORD DT PIRIE CM CHIDSEYFRINK KL MA YF JEE WSS THOMPSON DD

Citation: Hz. Ke et al., COMPARATIVE EFFECTS OF DROLOXIFENE, TAMOXIFEN, AND ESTROGEN ON BONE, SERUM-CHOLESTEROL, AND UTERINE HISTOLOGY IN THE OVARIECTOMIZED RAT MODEL, Bone, 20(1), 1997, pp. 31-39

ESTROGEN RECEPTOR-ALPHA KNOCKOUT (ERKO) MICE LOSE TRABECULAR AND CORTICAL BONE FOLLOWING OVARIECTOMY

Authors: PAN LC KE HZ SIMMONS HA CRAWFORD DT CHIDSEYFRINK KL MCCURDY SP SCHAFER JR KIMBRO KS TAKI M KORACH KS THOMPSON DD

Citation: Lc. Pan et al., ESTROGEN RECEPTOR-ALPHA KNOCKOUT (ERKO) MICE LOSE TRABECULAR AND CORTICAL BONE FOLLOWING OVARIECTOMY, Journal of bone and mineral research, 12, 1997, pp. 126-126

CP-336,156 PROTECTS AGAINST CANCELLOUS AND CORTICAL BONE LOSS IN OVARIECTOMIZED RATS - A PERIPHERAL QUANTITATIVE COMPUTED-TOMOGRAPHY (PQCT)STUDY

Authors: CRAWFORD DT CHIDSEYFRINK KL QI H PIRIE CM KE HZ THOMPSON DD

Citation: Dt. Crawford et al., CP-336,156 PROTECTS AGAINST CANCELLOUS AND CORTICAL BONE LOSS IN OVARIECTOMIZED RATS - A PERIPHERAL QUANTITATIVE COMPUTED-TOMOGRAPHY (PQCT)STUDY, Journal of bone and mineral research, 12, 1997, pp. 488-488

DROLOXIFENE INCREASES BONE MASS IN OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA

Authors: KE HZ CHIDSEYFRINK KL QI H CRAWFORD DT PIRIE CM SIMMONS HA THOMPSON DD

Citation: Hz. Ke et al., DROLOXIFENE INCREASES BONE MASS IN OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA, Journal of bone and mineral research, 12, 1997, pp. 494-494

PROSTAGLANDIN E-2 INCREASES MECHANICAL STRENGTH OF THE DISTAL FEMUR, FEMORAL-NECK, FEMORAL DIAPHYSIS AND LUMBAR VERTEBRAL BODY IN ADULT MALE-RATS

Authors: LIANG XG CRAWFORD DT CHIDSEYFRINK KL PIRIE CM SIMMONS HA THOMPSON DD SHEN V KE HZ

Citation: Xg. Liang et al., PROSTAGLANDIN E-2 INCREASES MECHANICAL STRENGTH OF THE DISTAL FEMUR, FEMORAL-NECK, FEMORAL DIAPHYSIS AND LUMBAR VERTEBRAL BODY IN ADULT MALE-RATS, Journal of bone and mineral research, 12, 1997, pp. 495-495

DROLOXIFENE DOES NOT BLUNT THE BONE ANABOLIC EFFECTS OF PROSTAGLANDINE(2) (PGE(2)) BUT MAINTAINS THE PGE(2)-RESTORED BONE IN OSTEOPENIC RATS

Authors: THOMPSON DD OI H CRAWFORD DT PIRIE CM SIMMONS HA KE HZ

Citation: Dd. Thompson et al., DROLOXIFENE DOES NOT BLUNT THE BONE ANABOLIC EFFECTS OF PROSTAGLANDINE(2) (PGE(2)) BUT MAINTAINS THE PGE(2)-RESTORED BONE IN OSTEOPENIC RATS, Journal of bone and mineral research, 11, 1996, pp. 1-1

CP-336,156, A HIGHLY POTENT ESTROGEN AGONIST ANTAGONIST, PREVENTS BONE LOSS, REDUCES TOTAL SERUM-CHOLESTEROL, BUT LACKS UTERINE STIMULATIVEEFFECT IN OVARIECTOMIZED RATS/

Authors: KE HZ CRAWFORD DT OI H CHIDSEYFRINK KL SIMMONS HA PIRIE CM CHEN HK JEE WSS ROSATI RL CAMERON KO TOLER SM JARDINE PD THOMPSON DD

Citation: Hz. Ke et al., CP-336,156, A HIGHLY POTENT ESTROGEN AGONIST ANTAGONIST, PREVENTS BONE LOSS, REDUCES TOTAL SERUM-CHOLESTEROL, BUT LACKS UTERINE STIMULATIVEEFFECT IN OVARIECTOMIZED RATS/, Journal of bone and mineral research, 11, 1996, pp. 251-251

DISCOVERY AND SAR OF A POTENT NONSTEROIDAL ESTROGEN AGONIST

Citation: Rl. Rosati et al., DISCOVERY AND SAR OF A POTENT NONSTEROIDAL ESTROGEN AGONIST, Journal of bone and mineral research, 11, 1996, pp. 591-591

DROLOXIFENE INHIBITS CORTICAL BONE TURNOVER ASSOCIATED WITH ESTROGEN DEFICIENCY IN RATS

Authors: CHEN HK ZE HZ LIN CH MA YF QI H CRAWFORD DT PIRIE CM SIMMONS HA JEE WSS THOMPSON DD

Citation: Hk. Chen et al., DROLOXIFENE INHIBITS CORTICAL BONE TURNOVER ASSOCIATED WITH ESTROGEN DEFICIENCY IN RATS, Bone, 17(4), 1995, pp. 175-179

COMPARATIVE EFFECTS OF DROLOXIFENE, TAMOXIFEN AND ESTROGEN ON BONE, SERUM-CHOLESTEROL, AND UTERINE HISTOLOGY IN THE OVARIECTOMIZED RAT

Authors: KE HZ CRAWFORD DT SIMMONS HA PIRIE CM OI H THOMPSON DD

Citation: Hz. Ke et al., COMPARATIVE EFFECTS OF DROLOXIFENE, TAMOXIFEN AND ESTROGEN ON BONE, SERUM-CHOLESTEROL, AND UTERINE HISTOLOGY IN THE OVARIECTOMIZED RAT, Journal of bone and mineral research, 10, 1995, pp. 143-143

DROLOXIFENE PREVENTS CANCELLOUS BONE LOSS AND INHIBITS BONE TURNOVER IN THE FEMORAL-NECK OF OVARIECTOMIZED RATS

Authors: OI H KE HZ CRAWFORD DT PIRIE CM SIMMONS HA THOMPSON DD

Citation: H. Oi et al., DROLOXIFENE PREVENTS CANCELLOUS BONE LOSS AND INHIBITS BONE TURNOVER IN THE FEMORAL-NECK OF OVARIECTOMIZED RATS, Journal of bone and mineral research, 10, 1995, pp. 198-198

DROLOXIFENE INHIBITS CORTICAL BONE TURNOVER ASSOCIATED WITH ESTROGEN DEFICIENCY IN RATS

Authors: CHEN HK KE HZ LIN CH MA YF",OI,"QI H CRAWFORD DT SIMMONS HA PIRIE CM JEE WSS THOMPSON DD

Citation: Hk. Chen et al., DROLOXIFENE INHIBITS CORTICAL BONE TURNOVER ASSOCIATED WITH ESTROGEN DEFICIENCY IN RATS, Journal of bone and mineral research, 10, 1995, pp. 355-355

DROLOXIFENE EFFECTS ON IGF BINDING PROTEIN-3 MAY MODULATE ITS LACK OFUTEROTROPHIC RESPONSES

Authors: PETERSEN DN THIEDE MA CRAWFORD DT KE HZ THOMPSON DD

Citation: Dn. Petersen et al., DROLOXIFENE EFFECTS ON IGF BINDING PROTEIN-3 MAY MODULATE ITS LACK OFUTEROTROPHIC RESPONSES, Journal of bone and mineral research, 10, 1995, pp. 390-390

DROLOXIFENE, A NEW ESTROGEN ANTAGONIST AGONIST, PREVENTS BONE LOSS INOVARIECTOMIZED RATS

Authors: KE HZ SIMMONS HA PIRIE CM CRAWFORD DT THOMPSON DD

Citation: Hz. Ke et al., DROLOXIFENE, A NEW ESTROGEN ANTAGONIST AGONIST, PREVENTS BONE LOSS INOVARIECTOMIZED RATS, Endocrinology, 136(6), 1995, pp. 2435-2441

Risultati: 1-17 |